496 related articles for article (PubMed ID: 33298155)
1. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of PM20D1 QTL in Alzheimer's disease.
Sanchez-Mut JV; Glauser L; Monk D; Gräff J
Clin Epigenetics; 2020 Feb; 12(1):20. PubMed ID: 32014019
[TBL] [Abstract][Full Text] [Related]
3. Harnessing peripheral DNA methylation differences in the Alzheimer's Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease.
Vasanthakumar A; Davis JW; Idler K; Waring JF; Asque E; Riley-Gillis B; Grosskurth S; Srivastava G; Kim S; Nho K; Nudelman KNH; Faber K; Sun Y; Foroud TM; Estrada K; Apostolova LG; Li QS; Saykin AJ;
Clin Epigenetics; 2020 Jun; 12(1):84. PubMed ID: 32539856
[TBL] [Abstract][Full Text] [Related]
4. Association of peripheral blood DNA methylation level with Alzheimer's disease progression.
Li QS; Vasanthakumar A; Davis JW; Idler KB; Nho K; Waring JF; Saykin AJ;
Clin Epigenetics; 2021 Oct; 13(1):191. PubMed ID: 34654479
[TBL] [Abstract][Full Text] [Related]
5. PM20D1 is a quantitative trait locus associated with Alzheimer's disease.
Sanchez-Mut JV; Heyn H; Silva BA; Dixsaut L; Garcia-Esparcia P; Vidal E; Sayols S; Glauser L; Monteagudo-Sánchez A; Perez-Tur J; Ferrer I; Monk D; Schneider B; Esteller M; Gräff J
Nat Med; 2018 May; 24(5):598-603. PubMed ID: 29736028
[TBL] [Abstract][Full Text] [Related]
6. CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.
Ma Y; Jun GR; Chung J; Zhang X; Kunkle BW; Naj AC; White CC; Bennett DA; De Jager PL; ; Mayeux R; Haines JL; Pericak-Vance MA; Schellenberg GD; Farrer LA; Lunetta KL
Aging Cell; 2019 Aug; 18(4):e12964. PubMed ID: 31144443
[TBL] [Abstract][Full Text] [Related]
7. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
[TBL] [Abstract][Full Text] [Related]
8. Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer's disease at CPT1A locus.
Sarnowski C; Huan T; Ma Y; Joehanes R; Beiser A; DeCarli CS; Heard-Costa NL; Levy D; Lin H; Liu CT; Liu C; Meigs JB; Satizabal CL; Florez JC; Hivert MF; Dupuis J; De Jager PL; Bennett DA; Seshadri S; Morrison AC
Clin Epigenetics; 2023 Oct; 15(1):173. PubMed ID: 37891690
[TBL] [Abstract][Full Text] [Related]
9. Mendelian randomization integrating GWAS and mQTL data identified novel pleiotropic DNA methylation loci for neuropathology of Alzheimer's disease.
Liu D; Wang Y; Jing H; Meng Q; Yang J
Neurobiol Aging; 2021 Jan; 97():18-27. PubMed ID: 33120085
[TBL] [Abstract][Full Text] [Related]
10. An epigenome-wide association study of Alzheimer's disease blood highlights robust DNA hypermethylation in the HOXB6 gene.
Roubroeks JAY; Smith AR; Smith RG; Pishva E; Ibrahim Z; Sattlecker M; Hannon EJ; Kłoszewska I; Mecocci P; Soininen H; Tsolaki M; Vellas B; Wahlund LO; Aarsland D; Proitsi P; Hodges A; Lovestone S; Newhouse SJ; Dobson RJB; Mill J; van den Hove DLA; Lunnon K
Neurobiol Aging; 2020 Nov; 95():26-45. PubMed ID: 32745807
[TBL] [Abstract][Full Text] [Related]
11. Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci.
Scelsi MA; Khan RR; Lorenzi M; Christopher L; Greicius MD; Schott JM; Ourselin S; Altmann A
Brain; 2018 Jul; 141(7):2167-2180. PubMed ID: 29860282
[TBL] [Abstract][Full Text] [Related]
12. Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
Xie B; Xu Y; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 56(1):391-401. PubMed ID: 27935556
[TBL] [Abstract][Full Text] [Related]
13. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease.
Semick SA; Bharadwaj RA; Collado-Torres L; Tao R; Shin JH; Deep-Soboslay A; Weiss JR; Weinberger DR; Hyde TM; Kleinman JE; Jaffe AE; Mattay VS
Acta Neuropathol; 2019 Apr; 137(4):557-569. PubMed ID: 30712078
[TBL] [Abstract][Full Text] [Related]
14. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.
Watson CT; Roussos P; Garg P; Ho DJ; Azam N; Katsel PL; Haroutunian V; Sharp AJ
Genome Med; 2016 Jan; 8(1):5. PubMed ID: 26803900
[TBL] [Abstract][Full Text] [Related]
16. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.
Haertle L; Müller T; Lardenoije R; Maierhofer A; Dittrich M; Riemens RJM; Stora S; Roche M; Leber M; Riedel-Heller S; Wagner M; Scherer M; Ravel A; Mircher C; Cieuta-Walti C; Durand S; van de Hove DLA; Hoffmann P; Ramirez A; Haaf T; El Hajj N; Mégarbané A
Clin Epigenetics; 2019 Dec; 11(1):195. PubMed ID: 31843015
[TBL] [Abstract][Full Text] [Related]
17. Epigenome-wide association study of Alzheimer's disease replicates 22 differentially methylated positions and 30 differentially methylated regions.
Li QS; Sun Y; Wang T
Clin Epigenetics; 2020 Oct; 12(1):149. PubMed ID: 33069246
[TBL] [Abstract][Full Text] [Related]
18. Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
Kobayashi N; Shinagawa S; Nagata T; Shimada K; Shibata N; Ohnuma T; Kasanuki K; Arai H; Yamada H; Nakayama K; Kondo K
PLoS One; 2016; 11(1):e0146449. PubMed ID: 26742120
[TBL] [Abstract][Full Text] [Related]
19. Common DNA methylation alterations of Alzheimer's disease and aging in peripheral whole blood.
Li H; Guo Z; Guo Y; Li M; Yan H; Cheng J; Wang C; Hong G
Oncotarget; 2016 Apr; 7(15):19089-98. PubMed ID: 26943045
[TBL] [Abstract][Full Text] [Related]
20. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
